Health Capital Helsinki
  • Home
  • Why Helsinki Metropolitan
  • About
  • News
  • Events
  • Opportunities
  • Careers
  • Contact
  • Search
  • Menu Menu
FIMM
Dec 2, 2020

Presenting Health Incubator Helsinki batch 1 companies:

VEIL.AI takes data anonymization and synthetization to the next level

There are vast amounts of health data that can not be properly used because it is sensitive, containing information of identifiable private citizens. However, if these privacy issues could be solved, this would open up brand new horizons for betterment of science – and, ultimately, people’s health. Helsinki startup VEIL.AI is developing advanced anonymization of data and ground-breaking synthetic data to solve this problem.

“Our unique technology makes it possible to use health data in ways that were not possible before,” says Tuomo Pentikäinen, CEO and Co-Founder of VEIL.AI.

VEIL.AI wants to facilitate accessibility and use of sensitive health data for new discoveries and better decision-making in healthcare. “We are committed to safe-keeping individual privacy with maximum privacy protection and data utility,” adds Pentikäinen.

As far as privacy is concerned, data security is different depending on the data content. The highest risk is with raw or original data, where all the identifying information is available. This is, obviously, high risk data.

“The next step is pseudonymized data where personal identifiers are masked to some degree. However, with some effort, the identities can often be figured out,” Pentikäinen describes this medium risk category.

Then there is anonymized data which has been scrubbed of all identifiable data and, also, of variable combinations that can be utilized to infer data subjects’ identity – this constitutes low risk data.

“Finally, there is synthetic data which is statistical data based on real data and data models. Here, the risk is minimal.”

Our unique technology makes it possible to use health data in ways that were not possible before.

Tuomo Pentikäinen VEIL.AI

Tuomo Pentikäinen, CEO and Co-Founder

Future is synthetic

According to Pentikäinen, synthetic data is a totally new philosophy of putting data together. “In the coming years, we expect the use of synthetic data to really take off.”

Anonymization and synthetization techniques can be used to achieve higher data quality and support those use cases when data comes from many sources.

“These techniques also comply better with GDPR and support use of Real World Data (RWD). Furthermore, there’s better privacy protection of real-time data and also complicated data types, such as genome, imaging and free text.”

In addition, the technology guarantees faster access to data and easier negotiation between data owners (controllers) and users.

VEIL. AI team members from left: Teemu Perheentupa, Robert Mills, Tuomo Pentikäinen, Mehreen Ali, Timo Miettinen and Janna Saarela

Anonymization engine up & running

At the core of VEIL.AI, we find the company’s anonymization engine: a brand new, powerful approach to de-identify personal or otherwise sensitive data.

“The anonymization engine facilitates sharing and analyzing data in low or zero-trust environments and ensures that neither anonymity nor data quality is compromised,” explains Pentikäinen.

The anonymization engine can be used at three levels: One-off anonymizations (e.g. piloting, research projects); continuous anonymization service (e.g. biobanks data access point); and as part of system architecture (e.g. anonymization competence and user interface implemented into hospital data lake).

The startup can handle several interesting data types, both in the realms of structured data and unstructured data. Under structured data, there are data types such as biobank data, registry data, clinical data and survey data. Unstructured data may be, for example, geo-location, genome or imaging data.

Synthetic data is a totally new philosophy of putting data together. In the coming years, we expect the use of synthetic data to really take off.

Expert edge

VEIL.AI is a spin-off from FIMM, Institute for Molecular Medicine Finland, which, in turn, is a research institute under the University of Helsinki. While VEIL.AI was established in February 2020, the technology in question has been in the works for about five years.

“Our key technology personnel have an experience of more than 20 years in demanding sensitive health data management projects,” says Pentikäinen.

VEIL.AI is one of the companies participating in Health Incubator Helsinki. Pentikäinen credits the program for a well-constructed process:

“We’ve seen different types of incubators and accelerators and Health Incubator Helsinki really stands out with its competence,” Pentikäinen says, adding that the experienced business mentors of the incubator can certainly push the participating startups onwards.

“We’re also very excited to be a part of a program where there are so many interesting companies from our field.”

Health TV: Health data, Tuesday 8 Dec

Join us on Tuesday 8 December to hear how to benefit from the best health data in the world. In the event, you’ll learn about the cutting-edge solutions of VEIL.AI and other Finnish health data companies. Sign up now!

Startup Fast Facts

Name: VEIL.AI

Product: Synthetization, anonymization and pseudonymization of health data

Founded: 2020

Team size: 9

Target customer/market: Pharma companies, hospitals, service providers for Life Science and Healthcare actors in the Nordic countries and Europe

More information:
Contact VEIL.AI
Health Incubator Helsinki – a unique long-term incubator program for research-based early stage teams and start-ups operating in the health sector in Finland and abroad

Previously published stories on Health Incubator Helsinki batch 1 companies:
SCellex targets single cell resolution to boost cancer research
Uute Scientific introduces natural microbes to cosmetic products to boost immune systems
MedicubeX brings healthcare to you – via automation
Medified created a new solution for mental health treatment
Maculaser combats blindness
EpiHeart fights off heart failure with new therapy

Text: Sami J. Anteroinen
Photos: VEIL.AI and FIMM Biobanking Infrastructures

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn

Other case stories

from Greater Helsinki

EsaDres team: Dr Marta Putrinš, Prof Karin Kogermann and Kairi Lorenz

EsaDres redefines wound care with tailored solutions

https://ecshuqpetk9.exactdn.com/wp-content/uploads/2024/10/EsaDres-team-2024.jpg?strip=all&lossy=1&quality=55&ssl=1 1016 2200 Saana Lehtinen https://ecshuqpetk9.exactdn.com/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png Saana Lehtinen2024-12-10 08:03:222024-12-12 14:13:44EsaDres redefines wound care with tailored solutions
Natal Mind team

Natal Mind is on a mission to revolutionise parental mental care

https://ecshuqpetk9.exactdn.com/wp-content/uploads/2024/12/natal_mind_team.jpg?strip=all&lossy=1&quality=55&ssl=1 1089 1812 Saana Lehtinen https://ecshuqpetk9.exactdn.com/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png Saana Lehtinen2024-12-08 19:40:232024-12-08 20:01:51Natal Mind is on a mission to revolutionise parental mental care

Ankerias is revolutionising chronic pain treatment with AI

Nov 4, 2024
https://ecshuqpetk9.exactdn.com/wp-content/uploads/2024/11/Ankerias_Tiimi-980x735-2.jpg?strip=all&lossy=1&quality=55&ssl=1 735 980 Saana Lehtinen https://ecshuqpetk9.exactdn.com/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png Saana Lehtinen2024-11-04 10:39:162024-11-08 11:25:48Ankerias is revolutionising chronic pain treatment with AI
All news

Health Capital Helsinki

Business Helsinki
Kansakoulukatu 3
00100 Helsinki
FINLAND

Privacy notice

Newsletter

Subscribe

Follow us

  • x
  • linkedin
Health Capital Helsinki
Scroll to top

We use cookies to give you the best experience on our website.

Find out more and set your preferences .

Powered by  GDPR Cookie Compliance
How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential website cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are necessary to deliver the website as intended, refusing them will have impact how our site functions. You can always block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will prompt you to accept or refuse cookies every time you revisit our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Third party cookies

This website uses Twitter's and LinkedIn's cookies to help us improve our content and reach.

Please enable essential website cookies first so that we can save your preferences!

Privacy notice

You can read about how we use your data on our Privacy notice page.

Privacy notice